What’s New in Antiretroviral Safety and Tolerability: Implications for Treatment

Download All
In this comprehensive online program led by expert faculty, review clinical strategies for applying the latest safety and tolerability data to minimize adverse events when selecting first-line ART and switching regimens in patients with HIV infection.
Kassem Bourgi, MD
Kristine Erlandson, MD
Rajesh T. Gandhi, MD
Daniel R. Kuritzkes, MD
Brian Wood, MD

Downloadable Slidesets

Review key data from AIDS 2020 and other sources informing individualized ART management to improve tolerability and minimize adverse events; topics include weight gain, cardiometabolic outcomes, and considerations for women of childbearing potential and during pregnancy.

Kassem Bourgi, MD Released: August 11, 2020

Review data and guideline recommendations informing ART management for specific patient populations to improve tolerability and minimize adverse events and potential drug-drug interactions

Kristine Erlandson, MD Rajesh T. Gandhi, MD Released: April 24, 2020

Review key data from 2020 conferences, including HIV Drug Therapy Glasgow and IDWeek, on potential causes and consequences of weight gain with ART and ART safety during conception or pregnancy.

Daniel R. Kuritzkes, MD Brian Wood, MD Released: November 9, 2020
Provided by USF Health

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings